Clinical Trial Update: Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of SPC1001 Low in patients with hypertension, including those with NYHA Class III/IV heart failure a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Heart Failure
• Hypertension

Drugs mentioned

• SPC1001 Low

Snippet

Sponsor: Shin Poong Pharmaceutical Co. Ltd. | Conditions: Hypertension (HTN), NYHA Class III Heart Failure | Phase 2 | Status: ENROLLING_BY_INVITATION